Cooper C. Collins

Cooper C. Collins is a declared insider of TherapeuticsMD, Inc., with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 10 August 2021 and the latest from 18 February 2025.

No open-market sale appears; the market trades are 4 purchases worth €585k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 option exercises.

Half of the purchases are above €36k and half below. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 20 February 2025 with an option exercise in TherapeuticsMD, Inc. The latest purchase dates back some time: it was published 783 days ago, on 26 August 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.